Quarterly report pursuant to Section 13 or 15(d)

SEGMENT INFORMATION (Details)

v3.8.0.1
SEGMENT INFORMATION (Details) - USD ($)
 3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Dec. 31, 2017
Revenues $ 307,913 $ 66,286  
Depreciation 123,379 26  
Interest expenses 236,986  
Net income (loss) (1,550,969) (549,333)  
Identifiable long-lived tangible assets 7,750,367   $ 7,671,786
Real property operating [Member]      
Revenues 296,623  
Depreciation 32,624  
Interest expenses 236,986  
Net income (loss) (237,700)  
Identifiable long-lived tangible assets 7,612,747   7,645,371
Development services and sales of developed products[Member]      
Revenues 11,290  
Depreciation 86,749  
Interest expenses  
Net income (loss) (173,474)  
Identifiable long-lived tangible assets 120,396   5,857
Medical related consulting services [Member]      
Revenues 66,286  
Depreciation 4,006 26  
Interest expenses  
Net income (loss) (100,132) (549,333)  
Identifiable long-lived tangible assets 17,224   $ 20,558
Others [Member]      
Net income (loss) [1] $ (1,039,663)  
[1] The Company does not allocate any general and administrative expense of its being a public company activities to its reportable segments as these activities are managed at a corporate level.